首页> Scientific reports> Assessing inhibitors of mutant isocitrate dehydrogenase using a suite of pre-clinical discovery assays.

Assessing inhibitors of mutant isocitrate dehydrogenase using a suite of pre-clinical discovery assays.

导出 LinkOut

翻译打印收藏纠错

第一作者： Daniel J,Urban

第一单位： NCATS Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, Maryland, 20850, United States.

作者： Daniel J,Urban ^[1] ; Natalia J,Martinez ^[1] ; Mindy I,Davis ^[1] ; Kyle R,Brimacombe ^[1] ; Dorian M,Cheff ^[1] ; Tobie D,Lee ^[1] ; Mark J,Henderson ^[1] ; Steven A,Titus ^[1] ; Rajan,Pragani ^[1] ; Jason M,Rohde ^[1] ; Li,Liu ^[1] ; Yuhong,Fang ^[1] ; Surendra,Karavadhi ^[1] ; Pranav,Shah ^[1] ; Olivia W,Lee ^[1] ; Amy,Wang ^[1] ; Andrew,McIver ^[2] ; Hongchao,Zheng ^[2] ; Xiaodong,Wang ^[2] ; Xin,Xu ^[1] ; Ajit,Jadhav ^[1] ; Anton,Simeonov ^[1] ; Min,Shen ^[1] ; Matthew B,Boxer ^[1] ; Matthew D,Hall ^[3]

作者单位： NCATS Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, Maryland, 20850, United States. ^[1] Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina School of Medicine, Chapel Hill, 27599, North Carolina, United States. ^[2] NCATS Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, Maryland, 20850, United States. hallma@mail.nih.gov. ^[3]